- $26.71bn
- $27.55bn
- $4.34bn
Illumina Inc reports results for the quarter ended June 30 - Earnings Summary
Illumina Q2 revenue falls 3%, but beats expectations
Brief: Illumina Enhances Flagship Assay To Accelerate Access To Comprehensive Tumor Profiling
U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx
U.S. STOCKS ON THE MOVE-Nvidia, Eli Lilly, Canopy Growth
Citi flags uncertainty in life science sector as funding shifts and tariffs bite
U.S. STOCKS ON THE MOVE-FVCBankcorp, Venture Global, Boeing
Citi flags uncertainty on life science sector as funding shifts and tariffs bite
Brief: Illumina To Buy Somalogic For $350 Million Plus $75 Million In Milestones
Brief: Illumina Inc - Enters Stock Purchase Agreement With Standard Biotools
Brief: Illumina To Acquire Somalogic, Accelerating Its Proteomics Business
Brief: Standard BioTools Enters Strategic Sale Of SomaLogic To Illumina
U.S. RESEARCH ROUNDUP- Caseys General Stores, Illumina, Starbucks
Brief: Illumina Expands Clinical Oncology Portfolio Unlocking New Standard Of Care And Access To Precision Therapies
U.S. STOCKS ON THE MOVE-Hims & Hers Health, TXNM Energy, Forge Global
U.S. STOCKS ON THE MOVE-Fox, Manpower Group, US chipmakers
US medical device makers gain after US and China agree to slash tariffs
U.S. STOCKS ON THE MOVE-NRG Energy, US drugmakers, KindlyMD
U.S. STOCKS ON THE MOVE-Oil firms, Apple, US big banks